Protéines recombinantes
Protéines modifiées ou manipulées codées par l'ADN recombinant et adaptées à divers usages, notamment la modification de séquences génétiques, la production massive de protéines et la fabrication de produits commerciaux.
À utiliser avec (application)
- (2)
- (2,347)
- (79)
- (3)
- (1)
- (1)
- (2)
- (354)
- (6,098)
- (7)
- (2)
- (7)
- (2)
- (1)
- (1)
- (2)
- (6)
- (43)
- (2)
- (2)
- (2)
- (2)
- (1)
- (2)
- (3)
- (1)
- (157)
- (1)
- (3)
- (1)
- (5)
- (10)
- (26,071)
- (1)
- (2)
- (1)
- (21)
- (1)
- (12,635)
- (1,160)
- (2)
- (2)
- (8)
- (1)
- (110)
- (8)
- (2)
- (1)
- (8)
- (1)
- (1)
- (1)
- (41)
- (255)
- (159)
- (1)
- (7)
- (1)
- (1)
- (3)
- (4)
- (1)
- (11,338)
- (25)
- (3)
- (30)
- (14)
- (15)
- (72)
- (13)
- (76)
- (78)
- (34)
- (1)
- (13)
- (1)
- (1,155)
- (1)
- (157)
- (26)
- (8)
- (1)
- (2)
- (2)
- (1)
- (18)
- (2)
- (21,642)
- (2,889)
- (4)
- (1)
- (2,842)
- (4)
- (6)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (11,317)
- (3)
- (6)
- (1)
- (1)
- (6)
- (7)
- (5)
- (1)
- (6)
- (1)
- (5,573)
- (6)
- (4)
- (3)
- (12)
- (2)
- (4)
- (5)
- (4)
- (5)
- (1)
- (13,020)
- (1,867)
- (1)
- (1)
Conjugué
- (11)
- (1)
- (4)
- (2)
- (9)
- (8)
- (1)
- (24)
- (1)
- (3)
- (1)
- (1)
- (3)
- (2)
- (1)
- (9)
- (2)
- (1)
- (13)
- (5)
- (1)
- (2)
- (3)
- (35,878)
Recombinant
- (70)
- (34,776)
Forme
- (1)
- (23,088)
- (9,226)
- (29)
- (146)
- (26)
- (35)
Statut réglementaire
- (79)
- (30,568)
Résultats de la recherche filtrée
Les produits de certains de nos fournisseurs ne s'affichent pas dans les résultats de la recherche filtrée. Veuillez
supprimer tous les filtres
pour voir ces produits.
Rechercher dans les résultats
Recherche par mot-clé:
Effacer la recherche
1
–
15
de
40,133
résultats
| Poids moléculaire (g/mol) | 17.4 kDa |
|---|---|
| Numéro d'enregistrement | P01375 |
| Séquence | VRSSSRTPSD KPVAHVVANP QAEGQLQWLN RRANALLANG VELRDNQLVV PSEGLYLIYS QVLFKGQGCP STHVLLTHTI SRIAVSYQTK VNLLSAIKSP CQRETPEGAE AKPWYEPIYL GGVFQLEKGD RLSAEINRPD YLDFAESGQV YFGIIAL |
| Concentration en endotoxines | <1 EU/μg |
| Activité biologique | The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Human TNF-alpha |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | Tnf |
| Nom usuel | TNF alpha |
| À utiliser avec (application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Alias du gène | APC1 protein; Cachectin; C-domain 1; C-domain 2; cTNF; DADB-70P7.1; DIF; ICD1; ICD2; Intracellular domain 1; Intracellular domain 2; N-terminal fragment; NTF; RATTNF; Tnf; TNF alpha; TNF superfamily; TNF α; TNF, macrophage-derived; TNF, monocyte-derived; TNFA; TNF-a; TNFalpha; TNF-alpha; Tnfsf1a; TNFSF2; TNFα; TNLG1F; Tumor necrosis factor; tumor necrosis factor (TNF superfamily, member 2); tumor necrosis factor alpha; tumor necrosis factor alpha (cachetin); tumor necrosis factor alpha precursor; tumor necrosis factor ligand 1F; tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor, membrane form; Tumor necrosis factor, soluble form; tumor necrosis factor-alpha; tumor necrosis factor-alpha precursor; tumor-necrosis factor; tumour necrosis factor |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 7124 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 8 kDa |
|---|---|
| Numéro d'enregistrement | P48061 |
| Séquence | KPVSLSYRCP CRFFESHVAR ANVKHLKILN TPNCALQIVA RLKNNNRQVC IDPKLKWIQE YLEKALNK |
| Concentration en endotoxines | <1 EU/μg |
| Activité biologique | Determined by its ability to chemoattract IL-2-activated human T cells using a concentration range of 20.0-80.0 ng/ml |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Human CXCL12 (SDF-1a) |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | CXCL12 |
| Nom usuel | CXCL12 alpha |
| À utiliser avec (application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Alias du gène | 12-O-tetradecanoylphorbol 13-acetate repressed protein 1; C Cmotif chemokine; C X C motif chemokine; CC motif chemokine; CCmotif chemokine; chemokine (C-X-C motif) ligand 12; chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1); CXC; CXC motif chemokine; C-X-C motif chemokine 12; C-X-C motif chemokine ligand 12; CXCL; Cxcl12; H-SDF-1-alpha; Intercrine reduced in hepatomas; IRH; Pbsf; pre-B cell growth-stimulating factor; pre-B-cell growth-stimulating factor; SCYB12; SDF 1 a; SDF 1 alpha; SDF 1α; SDF1; SDF-1; SDF1 alpha; SDF-1 gamma; SDF1A; SDF-1-alpha(3-67); SDF1B; SDF-1-beta(3-72); SDF1α; Stromal cell-derived factor 1; stromal cell-derived factor-1 alpha; stromal cell-derived factor-1 gamma; thymic lymphoma cell-stimulating factor; TLSF; Tpar1 |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 6387 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 23.9 kDa |
|---|---|
| Numéro d'enregistrement | P12644 |
| Séquence | KKNKNCRRHS LYVDFSDVGW NDWIVAPPGY QAFYCHGDCP FPLADHLNST NHAIVQTLVN SVNSSIPKAC CVPTELSAIS MLYLDEYDKV VLKNYQEMVV EGCGCR |
| Type de produit | Protein |
| Concentration en endotoxines | <1 EU/μg |
| Conjugué | Unconjugated |
| Nom | Human BMP-4 |
| Symbole de gène | BMP4 |
| À utiliser avec (application) | Bioactivity,Control,Western Blot Control |
| Forme | Lyophilized |
| Nom usuel | BMP4 |
| Alias du gène | BMP; BMP2B; BMP-2B; Bmp2b1; Bmp2b-1; Bmp4; Bmp-4; BOMPR4A; Bone morphogenetic protein; Bone morphogenetic protein 2B; bone morphogenetic protein 4; bone morphogenetic protein 4 preproprotein; DVR4; Dvr-4; MCOPS6; OFC11; ZYME |
| Conditions de stockage | -20°C |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. The expected ED50 for this effect is 5-10 ng/ml. |
| Système d’expression | E. coli |
| Méthode de purification | Purified |
| ID du gène (Entrez) | 652 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 17.2 kDa |
|---|---|
| Numéro d'enregistrement | P09038 |
| Séquence | AAGSITTLPA LPEDGGSGAF PPGHFKDPKR LYCKNGGFFL RIHPDGRVDG VREKSDPHIK LQLQAEERGV VSIKGVCANR YLAMKEDGRL LASKCVTDEC FFFERLESNN YNTYRSRKYT SWYVALKRTG QYKLGSKTGP GQKAILFLPM SAKS |
| Concentration en endotoxines | <1 EU/μg |
| Activité biologique | Determined by a cell proliferation assay using Balb/c 3T3 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Human FGF-basic (FGF-2/bFGF) (154 aa) |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | FGF2 |
| Nom usuel | FGF2 |
| À utiliser avec (application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Alias du gène | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Grade de qualité ou de pureté | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 2247 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 7.5 kDa |
|---|---|
| Forme de protéine | Recombinant, Ligand |
| Sous-type de protéine | IGFs (Insulin-Like Growth Factors) |
| Dosage biologique | proliferation of mouse FDC-P1 cells |
| Famille de protéines | Growth Factors & Receptors |
| Statut réglementaire | RUO |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Nom usuel | IGF1 |
| À utiliser avec (application) | Bioactivity |
| Alias du gène | C730016P09Rik; class 1 insulin-like growth factor I preproprotein; class 2 insulin-like growth factor I preproprotein; H-IGF-1; IBP1; IGF; IGF1; Igf-1; IGF1A; IGFI; Igf-I; IGFIa; IGF-IA; IGF-IB; insulin growth factor-1; Insulin like growth factor; insulin like growth factor 1; insulin-like growth factor 1; insulin-like growth factor 1 (somatomedin C); insulin-like growth factor I; insulin-like growth factor I (somatomedin C); insulin-like growth factor IB; mechano growth factor; MGF; M-IGF-1; OTTHUMP00000195084; prepro-IGF-I; prepro-insulin-like growth factor I; R-IGF-1; somatomedin; Somatomedin C; Somatomedin-C |
| Conditions de stockage | -20°C |
| Classification | Carrier-Free |
| Taux d’endotoxine | <1 EU/ml |
| Système d’expression | E. coli |
| Méthode de purification | Purified |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Numéro d'enregistrement | P05019 |
| Catégorie de recherche | Neurobiology, Drug Development, Oncology, Signal Transduction |
| Séquence | GPETLCGAEL VDALQFVCGD RGFYFNKPTG YGSSSRRAPQ TGIVDECCFR SCDLRRLEMY CAPLKPAKSA |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 ng/μg |
| Activité biologique | ED50 ≤ 2 ng/mL; determined by the dose-dependent proliferation of FDC-P1 cells. |
| Conjugué | Unconjugated |
| Espèces | Human |
| Nom | Human IGF-I |
| Symbole de gène | IGF1 |
| Grade de qualité ou de pureté | ≥98% by SDS-PAGE and HPLC |
| Activité | ED50 ≤ 2 ng/mL; determined by the dose-dependent proliferation of FDC-P1 cells. |
| ID du gène (Entrez) | 3479 |
| Poids moléculaire (g/mol) | 6.2 kDa |
|---|---|
| Forme de protéine | Recombinant, Ligand |
| Sous-type de protéine | EGF (Epidermal Growth Factor) |
| Famille de protéines | Growth Factors & Receptors |
| Statut réglementaire | RUO |
| Forme | Lyophilized |
| Contenu et stockage | 4°C |
| Nom usuel | EGF |
| À utiliser avec (application) | Bioactivity |
| Alias du gène | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Conditions de stockage | 4°C |
| Classification | Carrier-Free |
| Taux d’endotoxine | <0.1 ng/μg |
| Système d’expression | E. coli |
| Méthode de purification | Purified |
| Formule | Protein with no preservative |
| Gamme de produit | Gibco |
| Recombinant | Recombinant |
| Shipping condition (Condition d'expédition) | Wet Ice |
| Numéro d'enregistrement | P01133 |
| Catégorie de recherche | Stem Cell Research, Oncology |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 ng/μg |
| Activité biologique | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Conjugué | Unconjugated |
| Espèces | Human |
| Nom | Human EGF |
| Symbole de gène | EGF |
| Grade de qualité ou de pureté | >95% by SDS-PAGE |
| Activité | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| ID du gène (Entrez) | 1950 |
| Poids moléculaire (g/mol) | 16.8 kDa |
|---|---|
| Numéro d'enregistrement | P01579 |
| Séquence | MQDPYVKEAE NLKKYFNAGH SDVADNGTLF LGILKNWKEE SDRKIMQSQI VSFYFKLFKN FKDDQSIQKS VETIKEDMNV KFFNSNKKKR DDFEKLTNYS VTDLNVQRKA IHELIQVMAE LSPAAKTGKR KRSQMLFQGR RASQ |
| Concentration en endotoxines | <1 EU/μg |
| Activité biologique | The ED50 determined by a cytotoxicity assay using HT-29 cells is = 0.05 ng/ml, corresponding to a specific activity of = 2 x 10^7 units/mg |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Human IFN-gamma |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | IFNG |
| Nom usuel | IFN gamma |
| À utiliser avec (application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Alias du gène | BoIFNG; cytokine; EGK_03901; gamma interferon; gamma interferon precursor; gamma-interferon; gamma-interferon precursor (AA -23 to 143); H-IFN-g; IFG; IFI; IFN gamma; IFN γ; Ifng; IFN-g; IFNG2; IFN-gamma; IFN-gamma precursor; IFN-y; IFNγ; Immune interferon; Interferon; interferon gamma; interferon gamma precursor; interferon gamma type 2; Interferon y; Interferon γ; interferon, gamma; interferon-gama; interferon-gamma; Interferon-gamma level; interferon-gamma precursor; Interferonγ; M-IFN-g; R-IFN-g |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 3458 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 17.3 kDa |
|---|---|
| Numéro d'enregistrement | P01584 |
| Séquence | APVRSLNCTL RDSQQKSLVM SGPYELKALH LQGQDMEQQV VFSMSFVQGE ESNDKIPVAL GLKEKNLYLS CVLKDDKPTL QLESVDPKNY PKKKMEKRFV FNKIEINNKL EFESAQFPNW YISTSQAENM PVFLGGTKGG QDITDFTMQF VSS |
| Type de produit | Protein |
| Concentration en endotoxines | <1 EU/μg |
| Conjugué | Unconjugated |
| Nom | Human IL-1 beta |
| Symbole de gène | IL1B |
| À utiliser avec (application) | Bioactivity,Control,ELISA Standard,Western Blot Control |
| Forme | Lyophilized |
| Nom usuel | IL-1 beta |
| Alias du gène | catabolin; cytokine; Hematopoietin 1 (H1); IFN beta inducing factor; il 1b; IL 1β; IL-1; IL1 B; IL-1 beta; IL-1 precursor; IL1B; IL-1B; IL1B1; IL1beta; IL-1beta; IL1-BETA; IL1F2; IL1β; ILN; Interleukin; interleukin 1 beta; Interleukin 1 beta precursor; interleukin 1, beta; interleukin 1, beta 1; interleukin 1-beta; interleukin*1*beta; Interleukin1 beta; interleukin-1 beta; interleukin-1 beta precursor; interleukin-1 beta precursor (AA -113 to 153); interleukin-1 beta proprotein; interleukin-1b; interleukin-1beta; interleukin-beta; LAF; lymphocyte proliferation-potentiating factor; Osteoclast activating factor (OAF); preinterleukin 1 beta; Pro interleukin 1 beta; prointerleukin-1 beta; pro-interleukin-1-beta |
| Conditions de stockage | -20°C |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Activité | The ED50 as determined by the dose-dependent stimulation of thymidine uptake by murine D10S cells is ≤ 1.0 pg/ml, corresponding to a specific activity of ≥ 1 x 10^9 units/mg. |
| Système d’expression | E. coli |
| Méthode de purification | Purified |
| ID du gène (Entrez) | 3553 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 11 kDa |
|---|---|
| Numéro d'enregistrement | P29279 |
| Séquence | GKKCIRTPKI SKPIKFELSG CTSMKTYRAK FCGVCTDGRC CTPHRTTTLP VEFKCPDGEV MKKNMMFIKT CACHYNCPGD NDIFESLYYR KMYGDMA |
| Concentration en endotoxines | <1 EU/μg |
| Activité biologique | Determined by its ability to stimulate the proliferation of mouse Balb/c 3T3 cells. |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Human CTGF (CCN2) |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | CCN2 |
| Nom usuel | CTGF |
| À utiliser avec (application) | Bioactivity,Control,ELISA Standard,Western Blot Control |
| Alias du gène | 2-Nov; betaIG-M2; CCN family member 2; Ccn2; Cellular communication network factor 2; connective tissue growth factor; connective tissue growth factor precursor; Connective tissue growth factor precursor (CTGF) (FISP-12 protein) (Hypertrophic chondrocyte-specific protein 24); connective tissue growth-related protein; CTGF; CTGF protein; CTGRP; fibroblast inducible secreated protein; fibroblast inducible secreted protein; Fisp12; fisp-12; Hcs24; H-CTGF; hypertrophic chondrocyte-specific gene product 24; hypertrophic chondrocyte-specific protein 24; IBP-8; IGF-binding protein 8; IGFBP8; IGFBP-8; Insulin-like growth factor-binding protein 8; MGC102839; NOV2; Protein FISP-12; similar to connective tissue growth factor precursor |
| Grade de qualité ou de pureté | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 1490 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 56.3 kDa |
|---|---|
| Numéro d'enregistrement | Q15389 |
| Séquence | SNQRRSPENS GRRYNRIQHG QCAYTFILPE HDGNCRESTT DQYNTNALQR DAPHVEPDFS SQKLQHLEHV MENYTQWLQK LENYIVENMK SEMAQIQQNA VQNHTATMLE IGTSLLSQTA EQTRKLTDVE TQVLNQTSRL EIQLLENSLS TYKLEKQLLQ QTNEILKIHE KNSLLEHKIL EMEGKHKEEL DTLKEEKENL QGLVTRQTYI IQELEKQLNR ATTNNSVLQK QQLELMDTVH NLVNLCTKEG VLLKGGKREE EKPFRDCADV YQAGFNKSGI YTIYINNMPE PKKVFCNMDV NGGGWTVIQH REDGSLDFQR GWKEYKMGFG NPSGEYWLGN EFIFAITSQR QYMLRIELMD WEGNRAYSQY DRFHIGNEKQ NYRLYLKGHT GTAGKQSSLI LHGADFSTKD ADNDNCMCKC ALMLTGGWWF DACGPSNLNG MFYTAGQNHG KLNGIKWHYF KGPSYSLRST TMMIRPLDFH HHHHH |
| Type de produit | Protein |
| Concentration en endotoxines | <1 EU/μg |
| Conjugué | Unconjugated |
| Nom | Human ANG-1 |
| Symbole de gène | Angpt1 |
| À utiliser avec (application) | Bioactivity,Control |
| Forme | Lyophilized |
| Nom usuel | Angiopoietin 1 |
| Alias du gène | 1110046O21Rik; 2810039D03Rik; AGP1; Agpt; Agpt1; ANG1; ang-1; ANG3; ANG-3; angioarrestin; angiopoietin 1; angiopoietin 3; angiopoietin like 1; angiopoietin Y1; angiopoietin-1; Angiopoietin-3; angiopoietin-like 1; angiopoietin-like protein 1; Angiopoietin-related protein 1; Angpt1; ANGPT3; Angptl1; AngY; ARP1; dJ595C2.2; dJ595C2.2 (angiopoietin Y1); endothelial growth factor; KIAA0003; PSEC0154; tie2 receptor ligand; UNQ162; UNQ162/PRO188 |
| Conditions de stockage | -20°C |
| Grade de qualité ou de pureté | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by its ability to induce adhesion of human umbilical vein endothelial cells (HUVEC). |
| Système d’expression | HeLa cells |
| Méthode de purification | Purified |
| ID du gène (Entrez) | 284 |
| Étiquette de la protéine | His-tag |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Plage de pH | 7.4 |
|---|---|
| Poids moléculaire (g/mol) | 13.5 kDa |
| Forme de protéine | Recombinant, Ligand |
| Sous-type de protéine | Interleukins |
| Famille de protéines | Cytokines & Receptors |
| Statut réglementaire | RUO |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Nom usuel | IL-4 |
| À utiliser avec (application) | Bioactivity |
| Alias du gène | B cell growth factor 1; B_cell stimulatory factor 1; B-cell growth factor 1; B-cell IgG differentiation factor; B-cell stimulatory factor 1; BCGF1; BCGF-1; binetrakin; BSF1; BSF-1; cytokine; H-IL-4; IGG1 induction factor; IL2; IL4; Il-4; Il4e12; ILN; Interleukin; interleukin 4; interleukin 4 variant 2; interleukin 4 variant IL-4delta2; interleukin 4 variant IL-4delta3; interleukin 4 variant IL-4int2A; interleukin 4 variant IL-4int3A; interleukin 4 variant IL-4int3B; Interleukin4; interleukin-4; interleukin-4 precursor; lymphocyte stimulatory factor 1; MGC79402; M-IL-4; Pitrakinra |
| Conditions de stockage | -20°C |
| Système d’expression | E. coli |
| Méthode de purification | Purified |
| Formule | PBS with no preservative; pH 7.4 |
| Gamme de produit | Gibco |
| Recombinant | Recombinant |
| Shipping condition (Condition d'expédition) | Approved for shipment on Wet or Dry Ice |
| Numéro d'enregistrement | P07750 |
| Catégorie de recherche | Immunology, Stem Cell Research, Inflammation |
| Séquence | MHIHGCDKNH LREIIGILNE VTGEGTPCTE MDVPNVLTAT KNTTESELVC RASKVLRIFY LKHGKTPCLK KNSSVLMELQ RLFRAFRCLD SSISCTMNES KSTSLKDFLE SLKSIMQMDY S |
| Type de produit | Protein |
| Activité biologique | ED50 = 2 ng/mL; determined by the dose-dependent proliferation of mouse HT-2 cells. |
| Conjugué | Unconjugated |
| Espèces | Mouse |
| Nom | Mouse IL-4 |
| Symbole de gène | Il4 |
| Grade de qualité ou de pureté | >96% by SDS-PAGE and RP-HPLC |
| Activité | ED50 ≤ 2 ng/mL; determined by the dose-dependent proliferation of mouse HT-2 cells. |
| ID du gène (Entrez) | 16189 |
Invitrogen™ eBioscience™ Concanavalin A (Con A) Solution (500X)
The Concanavalin A (Con A) Solution (500X) is a ready-to-use solution of Con A in aqueous buffer.
| Format | Vial |
|---|---|
| Sous-type de protéine | Lectins |
| Sources | Canavlia Ensiformis |
| Gamme de produit | eBioscience |
| Forme | Solution |
